SADR

(redirected from Serious Adverse Drug Reaction)
Also found in: Medical.
AcronymDefinition
SADRSender Attachment Delay Recorder
SADRSahrawi Arab Democratic Republic (Western Sahara)
SADRStandard Ambulatory Data Record
SADRSuper Agent Distributed Repository
SADRSerious Adverse Drug Reaction
SADRStand Alone Disaster Recovery
SADRSelective Address
SADRSecure Acoustic Data Relay
SADRSatellite Data Relay
References in periodicals archive ?
Under the proposed regulations, hospitals will be required to report to Health Canada all serious adverse drug reactions and medical device incidents, in writing, within 30 days of when the incident was first documented within the hospital.
Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.
The serious adverse drug reactions (ADRs) associated with ADVATE were hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to Factor VIII.
It also enables the identification of signals of serious adverse drug reactions; ways to evaluate causality, clinical relevance, and the frequency and distribution of reactions in specific populations; identification and evaluation of events that affect adherence to treatment and risk factors; and communication and recommendations to authorities and the public, appropriate responses, evaluation of outcomes, and feedback to clinicians.
"If parents, carers or young people are unsure how best to treat these problems they should ask a GP, health visitor, dentist or pharmacist for advice." As of April 16 this year, three suspected serious adverse drug reactions reports were received by the MHRA in association with the use of oral gels containing choline salicylate, including Bonjela.
"There are a number of options and alternative treatments for pain associated with teething and mouth ulcers." As of April 16 this year, three suspected serious adverse drug reactions (ADR) reports were received by the MHRA in association with the use of oral gels containing choline salicylate, including Bonjela.
A group of eight of the largest drug manufacturers has formed a consortium to study the genetics of serious adverse drug reactions.